15 Articles
15 Articles
All
Left
11
Center
2
Right
1
Aptose Upgraded to Trade on OTCQB Market
SAN DIEGO and TORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly…
Coverage Details
Total News Sources15
Leaning Left11Leaning Right1Center2Last UpdatedBias Distribution79% Left
Bias Distribution
- 79% of the sources lean Left
79% Left
L 79%
14%
Factuality
To view factuality data please Upgrade to Premium